logo
‘Psychology Of Winning' Pioneer Denis Waitley Dead At 92

‘Psychology Of Winning' Pioneer Denis Waitley Dead At 92

Forbes19-06-2025
Dr. Denis Waitley, speaking on the Psychology of Winning, at the Wentworth Hotel, June 27, 1980. ... More (Photo by Paul Stephen Pearson/Fairfax Media via Getty Images).
Famed motivational psychologist Dr. Denis Waitley died in his sleep on June 7th, 2025. He was a major player in a new phenomenon that arose in America – the motivational rally. In auditoriums and convention centers, businesspeople, educators, salespeople, and homemakers gathered to hear speakers such as Norman Vincent Peale, Zig Ziglar, and Art Linkletter, among others, extol the virtues of positive thinking, unbridled optimism, and hard work.
Waitley's The Psychology of Winning self-development program would go on to sell over two million copies and capture the hearts of many baby boomer age adherents, eager to carve out their place in the world.
Waitley's message was built on his study of the traits that high-achieving people have in common. As a young magazine journalist, I interviewed Waitley in 1982 and asked him which characteristic, above all others, seemed to define winners from the rest of the pack?
'It's their understanding of the degree of control that their thoughts have over the actions that follow in their lives," he said. "Whether they are astronauts, parents, or prisoners of war, these individuals have taken responsibility for their actions. The deepest, most significant choice we make is in the way we choose to think."
The difference between winners and losers, Waitley taught, was in what he called a person's 'self-talk.' 'The mind is talking to itself constantly at some eight hundred words per minute. Winners, he found, think constantly in terms of 'I can,' "I will,' and 'I am,' while losers concentrate their waking thoughts on what they should have or would have done, or what they can't do.
When our self-talk is positive, Waitley observed, the mind then goes to work instructing the body to carry out the performance of the thought as if it had already been achieved before and is merely being repeated.
Waitley would go on to sell these ideas and many others to audiences of self-improvers worldwide. He spent more than four decades on the international speaking circuit, logging an average of 500,000 miles each year, helping people—from astronauts to Olympic athletes, corporate leaders to schoolchildren—redefine success from the inside out. Waitley's clients included everyone from members of the U.S. Olympic team to Super Bowl champions, as well as scores of corporate clients.
Waitley was the former Chairman of Psychology for the U.S. Olympic Committee's Sports Medicine Council and authored 16 books, including classics such as Seeds of Greatness, The Winner's Edge, and Empires of the Mind. He was invited to join NASA's astronaut training program, where he worked with space shuttle crews on mental preparation. Around the same time, he began coaching elite athletes on visualization techniques. He popularized the use of guided imagery and mental rehearsal long before it became mainstream.
His speeches—delivered with laid-back authority, a radio announcer's voice, and self-effacing storytelling—centered on mental toughness, personal responsibility, and visions of a brighter future. Forty years after my interview with Waitley, his observations ring relevant today.
When asked to summarize his primary message, he responded: 'The period we're living in is no worse than any other period in history, and probably better. Since society is changing rapidly, it's up to the individual to view change as normal, and to see many of the changes taking place as positive rather than negative.'
Yet behind the inspiring keynotes and bestselling books was a man whose private life was marked by turmoil. Born in 1942, Waitley grew up in Depression-era San Diego, California. His mother worked in a factory, and his father was a warehouseman. They soon divorced. 'One night my father came into our bedroom to say goodbye,' Waitley recalled in an interview with Success Magazine. 'We didn't see him again for six years.'
Waitley's struggle to break free of a loser mindset and shift into an abundant winner's mindset propelled his determination to make something of himself. 'I wrote The Psychology of Winning while I was losing,' Waitley recalled. 'I wanted to remind myself what I needed to do to change myself from loser to winner.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Investors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three years
Investors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three years

Yahoo

time37 minutes ago

  • Yahoo

Investors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three years

It is doubtless a positive to see that the OptimizeRx Corporation (NASDAQ:OPRX) share price has gained some 73% in the last three months. But that is small recompense for the exasperating returns over three years. Indeed, the share price is down a tragic 55% in the last three years. Some might say the recent bounce is to be expected after such a bad drop. While many would remain nervous, there could be further gains if the business can put its best foot forward. It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Because OptimizeRx made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size. Over three years, OptimizeRx grew revenue at 16% per year. That's a fairly respectable growth rate. So some shareholders would be frustrated with the compound loss of 16% per year. The market must have had really high expectations to be disappointed with this progress. So this is one stock that might be worth investigating further, or even adding to your watchlist. The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail). We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. So we recommend checking out this free report showing consensus forecasts It's good to see that OptimizeRx has rewarded shareholders with a total shareholder return of 34% in the last twelve months. Notably the five-year annualised TSR loss of 1.3% per year compares very unfavourably with the recent share price performance. The long term loss makes us cautious, but the short term TSR gain certainly hints at a brighter future. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - OptimizeRx has 1 warning sign we think you should be aware of. If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

The heat has a surprising effect on the brain — here's what doctors want you to know
The heat has a surprising effect on the brain — here's what doctors want you to know

Fox News

time42 minutes ago

  • Fox News

The heat has a surprising effect on the brain — here's what doctors want you to know

Summer heat has swept the U.S., with warnings issued across the East Coast and Midwest. In addition to putting stress on the body, hot weather can also take a toll on the brain and mental health. Dr. Jace Reed, director of emergency psychiatry at Cedars-Sinai Hospital in Los Angeles, emphasized in an interview with Fox News Digital that the brain is a major organ that can be greatly affected by heat. Extreme heat can cause mental health changes like increased irritability and anxiety, along with decreased memory, attention and reaction time. This can affect daily interactions socially and professionally, the expert cautioned. "You may be slower at completing your task or remembering what someone just told you," he told Fox News Digital. "Those can be initial early signs that the heat is affecting your brain and your mental abilities." Symptoms like extreme confusion could mark the beginning of a heat stroke, which could require hospitalization, the psychiatrist warned. In a separate interview with Fox News Digital, Thea Gallagher, a doctor of psychology and director of wellness programs at NYU Langone Health, noted that when the body overheats, it struggles to regulate internal balance. This can lead to disrupted sleep, fatigue and poor concentration, as well as impaired cognitive function, slow reaction times and struggles with decision-making. The heat can also increase oxidative stress and inflammation in the brain, Gallagher added, which can potentially damage neurons, worsen existing neurological conditions and raise stroke risk. "Heat exposure may trigger an inflammatory response in the brain," she said. "In cases like heatstroke, inflammation is believed to contribute to symptoms such as confusion and delirium." Excessive heat can also weaken the protective blood-brain barrier, according to the expert, which makes the brain more vulnerable to toxins and pathogens. Higher temperatures are also associated with disturbances in mood and violent behavior, especially during prolonged heatwaves. Psychiatric emergency visits for anxiety, depression and substance use also rise significantly on the hottest days, Gallagher confirmed. Below are some of the main mental symptoms that can worsen in hot weather, experts cautioned. People who suffer from mental health conditions such as mood disorders, schizophrenia, anxiety or even dementia are more vulnerable in hot weather. Some psychiatric medications could make it difficult for the body to regulate temperature or stay hydrated, Gallagher noted, while heat can "intensify" symptoms like agitation or paranoia. "People with cognitive impairments may not recognize the signs of overheating," she added. "Some SSRIs (selective serotonin reuptake inhibitors) can suppress sweat production, which is the body's primary cooling mechanism. This raises the risk of overheating, dehydration and even heat stroke." "Paradoxically, SSRIs can also cause excessive sweating in some individuals — a side effect known as 'SSRI sweats,'" she went on. "While this might seem like it would help with cooling, it can actually lead to dehydration if fluid intake doesn't keep up." The experts recommended the following practices to protect brain health in extreme heat. For more Health articles, visit "Days are also longer and there are more activities, which can be exhausting," Gallagher noted. "Therefore, it is good to prioritize sleep and rest … and [find] ways to slow down when you can."

What to Expect From Universal Health Services' Next Quarterly Earnings Report
What to Expect From Universal Health Services' Next Quarterly Earnings Report

Yahoo

timean hour ago

  • Yahoo

What to Expect From Universal Health Services' Next Quarterly Earnings Report

King of Prussia, Pennsylvania-based Universal Health Services, Inc. (UHS) owns and operates acute care hospitals, and outpatient and behavioral health care facilities. Valued at a market cap of $12 billion, the company's range of services include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and behavioral health services. It is expected to announce its fiscal Q2 earnings for 2025 on Wednesday, Jul. 23. Prior to this event, analysts project this healthcare company to report a profit of $4.87 per share, up 13% from $4.31 per share in the year-ago quarter. The company has exceeded Wall Street's bottom-line estimates in three of the last four quarters, while missing on another occasion. Its earnings of $4.84 per share in the previous quarter outpaced the consensus estimates by 11%. Is UnitedHealth Stock a Buy, Sell, or Hold for July 2025? Michael Saylor Says 'You'll Wish You'd Bought More' Bitcoin as MicroStrategy Doubles Down Is Microsoft Stock About to Go Nuclear? Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! For the full year, analysts expect UHS to report EPS of $19.43, up 17% from $16.61 in fiscal 2024. Furthermore, its EPS is expected to grow 8.9% year-over-year to $21.16 in fiscal 2026. UHS has declined marginally over the past 52 weeks, lagging behind the S&P 500 Index's ($SPX) 13% return over the same time frame. However, it has outpaced the Health Care Select Sector SPDR Fund's (XLV) 6.3% downtick over the same time period. On Apr. 28, UHS released its Q1 results, and its shares closed down marginally in the following trading session. The company's overall revenue improved 6.7% year-over-year to $4.1 billion but fell short of the consensus estimates by nearly 1%. Meanwhile, on the earnings front, due to favorable pricing and margin improvement, the company's adjusted EPS surged 30.8% year-over-year to $4.84 and surpassed the analyst estimates by 11%. Wall Street analysts are moderately optimistic about UHS' stock, with a "Moderate Buy" rating overall. Among 19 analysts covering the stock, eight recommend "Strong Buy," and 11 advise 'Hold.' The mean price target for UHS is $226.19, which indicates a 22.6% potential upside from the current levels. On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store